IGEX (Indo Global Exchange(s) Pte) EBITDA Margin %: % (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Indo Global Exchange(s) Pte EBITDA Margin %?

Indo Global Exchange(s) Pte IGEX EBITDA Margin % is % as of Apr. 2026.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Indo Global Exchange(s) Pte's EBITDA for the three months ended in Apr. 2026 was $0.00 Mil. Indo Global Exchange(s) Pte's Revenue for the three months ended in Apr. 2026 was $0.00 Mil. Therefore, Indo Global Exchange(s) Pte's EBITDA margin for the quarter that ended in Apr. 2026 was %.

Indo Global Exchange(s) Pte  (OTCPK:IGEX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Indo Global Exchange(s) Pte EBITDA Margin % Related Terms

Indo Global Exchange(s) Pte EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Indo Global Exchange(s) Pte's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo Global Exchange(s) Pte EBITDA Margin % Chart

Indo Global Exchange(s) Pte Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 264.45 -

Indo Global Exchange(s) Pte Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Jan26 Apr26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

IGEX vs PHIL, AAMTF, QMCI: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Indo Global Exchange(s) Pte's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indo Global Exchange(s) Pte EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indo Global Exchange(s) Pte's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Indo Global Exchange(s) Pte's EBITDA Margin % falls into.


Indo Global Exchange(s) Pte EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Indo Global Exchange(s) Pte's EBITDA Margin % for the fiscal year that ended in Jul. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Jul. 2025 )/Revenue (A: Jul. 2025 )
=-0.192619/0
= %

Indo Global Exchange(s) Pte's EBITDA Margin % for the quarter that ended in Apr. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of % mean?
Indo Global Exchange(s) Pte (IGEX) has a EBITDA Margin % of % as of Apr. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Indo Global Exchange(s) Pte and its competitors.
Is Indo Global Exchange(s) Pte's EBITDA Margin % too high?
Indo Global Exchange(s) Pte's current EBITDA Margin % is %.
How does Indo Global Exchange(s) Pte's EBITDA Margin % compare to PHIL and AAMTF?
Indo Global Exchange(s) Pte's EBITDA Margin % of % can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 11.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 11.88, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Indo Global Exchange(s) Pte and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 11.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo Global Exchange(s) Pte's current EBITDA Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo Global Exchange(s) Pte stock overvalued right now?
Indo Global Exchange(s) Pte (IGEX) has a current EBITDA Margin % of %. The current EBITDA Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Indo Global Exchange(s) Pte (IGEX), the current EBITDA Margin % is % as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo Global Exchange(s) Pte Business Description

Address 6400 S. Fiddlers Green, No. 250 No.1012, Greenwood Village, CO, USA, 80111
Indo Global Exchange(s) Pte Ltd is a holding company. The company is focusing on developing assets within the pharmaceutical and nutraceutical industries.